NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Fusion Pharmaceuticals Inc (NASDAQ: FUSN)

 
FUSN Technical Analysis
2
As on 9th Jun 2023 FUSN STOCK Price closed @ 4.95 and we RECOMMEND Buy for LONG-TERM with Stoploss of 4.37 & Strong Sell for SHORT-TERM with Stoploss of 6.78 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

FUSNSTOCK Price

Open 4.99 Change Price %
High 5.14 1 Day -0.03 -0.60
Low 4.90 1 Week -0.15 -2.94
Close 4.95 1 Month 1.08 27.91
Volume 34804 1 Year -0.05 -1.00
52 Week High 8.57 | 52 Week Low 1.98
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
FUSN
Daily Charts
FUSN
Intraday Charts
Whats New @
Bazaartrend
FUSN
Free Analysis
 
FUSN Important Levels Intraday
RESISTANCE5.41
RESISTANCE5.26
RESISTANCE5.17
RESISTANCE5.08
SUPPORT4.82
SUPPORT4.73
SUPPORT4.64
SUPPORT4.49
 
FUSN Forecast May 2024
4th UP Forecast13.14
3rd UP Forecast10.51
2nd UP Forecast8.89
1st UP Forecast7.27
1st DOWN Forecast2.63
2nd DOWN Forecast1.01
3rd DOWN Forecast-0.61
4th DOWN Forecast-3.24
 
FUSN Weekly Forecast
4th UP Forecast6.72
3rd UP Forecast6.15
2nd UP Forecast5.80
1st UP Forecast5.45
1st DOWN Forecast4.45
2nd DOWN Forecast4.10
3rd DOWN Forecast3.75
4th DOWN Forecast3.18
 
FUSN Forecast2024
4th UP Forecast17.96
3rd UP Forecast13.79
2nd UP Forecast11.21
1st UP Forecast8.63
1st DOWN Forecast1.27
2nd DOWN Forecast-1.31
3rd DOWN Forecast-3.89
4th DOWN Forecast-8.06
 
 
FUSN Other Details
Segment EQ
Market Capital 308020320.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
FUSN Address
FUSN
 
FUSN Latest News
 
Your Comments and Response on Fusion Pharmaceuticals Inc
 
FUSN Business Profile
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Its lead product candidate is FPI-1434 that is in Phase 1 clinical trials as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. The company is also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, it is progressing its earlier-stage product candidate, FPI-1966 into clinical development for the treatment of head and neck, and bladder cancers expressing fibroblast growth factor receptor. The company was founded in 2014 and is headquartered in Hamilton, Canada. Address: 270 Longwood Road South, Hamilton, ON, Canada, L8P 0A6
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service